Back

Combined effect of frailty and sarcopenia on the risk of cardiovascular disease: a longitude analysis in middle-aged and older adults

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in older adults (1) Cardiovascular Disease in the Elderly ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Menglu Liu

Beijing (China)

7 More presentations in this session

Presentation thumbnail
Comparative safety and efficacy of combination lipid lowering therapy versus high-intensity statin in elderly patients with atherosclerotic cardiovascular disease
Doctor J. Cha (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Association of GlycA, a composite 1H-NMR marker of systemic inflammation, with LDL particle size, frailty and epigenetic age acceleration
Associate Professor E. Fung (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of drug-coated balloon vs. drug-eluting stent in octogenarians with coronary artery disease: a propensity score-matched study
Professor A. Her (Chuncheon, KR)
Abstract Slides Video
Presentation thumbnail
Baseline levels of amino acid metabolites are associated with clinical outcomes in older persons
Doctor C. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Diagnostic value of 24-hour holter monitoring in nonagenarians: a single-center cohort study
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in older adults (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The relaionship of frailty indices on survival in elderly patients with severe valvular heart diseases
thumbnail
Congress Presentation
Association between adherence to LS7 and frailty among older US adults
thumbnail
Congress Presentation
Long-term changes in frailty and incident atrial fibrillation: multicenter prospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources